466 related articles for article (PubMed ID: 15000529)
41. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
42. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons.
Pinto A; Gillard S; Moss F; Whyte K; Brust P; Williams M; Stauderman K; Harpold M; Lang B; Newsom-Davis J; Bleakman D; Lodge D; Boot J
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8328-33. PubMed ID: 9653186
[TBL] [Abstract][Full Text] [Related]
43. Serum and plasma from patients with Lambert-Eaton Myasthenic Syndrome reduce depolarization-dependent uptake of 45Ca2+ into rat cortical synaptosomes.
Hewett SJ; Atchison WD
Brain Res; 1991 Dec; 566(1-2):320-4. PubMed ID: 1814548
[TBL] [Abstract][Full Text] [Related]
44. Antibodies to active zone protein ERC1 in Lambert-Eaton myasthenic syndrome.
Huijbers MG; Lipka AF; Potman M; Hensbergen PJ; Titulaer MJ; Niks EH; van der Maarel SM; Klooster R; Verschuuren JJ
Hum Immunol; 2013 Jul; 74(7):849-51. PubMed ID: 23583364
[TBL] [Abstract][Full Text] [Related]
45. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
Giovannini F; Sher E; Webster R; Boot J; Lang B
Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
[TBL] [Abstract][Full Text] [Related]
46. [Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases].
Takamori M
Brain Nerve; 2011 Jul; 63(7):635-40. PubMed ID: 21747132
[TBL] [Abstract][Full Text] [Related]
47. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
[TBL] [Abstract][Full Text] [Related]
48. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
Engisch KL; Rich MM; Cook N; Nowycky MC
J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
[TBL] [Abstract][Full Text] [Related]
49. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
[TBL] [Abstract][Full Text] [Related]
50. Lambert-Eaton myasthenic syndrome.
Mareska M; Gutmann L
Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
[TBL] [Abstract][Full Text] [Related]
51. 3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
Wirtz PW; Titulaer MJ; Gerven JM; Verschuuren JJ
Expert Rev Clin Immunol; 2010 Nov; 6(6):867-74. PubMed ID: 20979551
[TBL] [Abstract][Full Text] [Related]
52. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395
[TBL] [Abstract][Full Text] [Related]
53. Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels.
Martin-Moutot N; el Far O; Leveque C; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M; Seagar MJ
J Physiol Paris; 1993; 87(1):37-41. PubMed ID: 8305896
[TBL] [Abstract][Full Text] [Related]
54. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Johnston I; Lang B; Leys K; Newsom-Davis J
Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
[TBL] [Abstract][Full Text] [Related]
55. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
[TBL] [Abstract][Full Text] [Related]
56. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
[TBL] [Abstract][Full Text] [Related]
57. Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States.
Ginebaugh SP; Badawi Y; Tarr TB; Meriney SD
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740866
[TBL] [Abstract][Full Text] [Related]
58. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.
Smith DO; Conklin MW; Jensen PJ; Atchison WD
J Physiol; 1995 Aug; 487(1):115-23. PubMed ID: 7473242
[TBL] [Abstract][Full Text] [Related]
59. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
Schneider I; Kornhuber ME; Hanisch F
J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
[TBL] [Abstract][Full Text] [Related]
60. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
